Your browser doesn't support javascript.
loading
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.
Coffey, Greg P; Feng, Jiajia; Betz, Andreas; Pandey, Anjali; Birrell, Matt; Leeds, Janet M; Der, Kenneth; Kadri, Sabah; Lu, Pin; Segal, Jeremy; Wang, Y Lynn; Michelson, Glenn; Curnutte, John T; Conley, Pamela B.
Afiliación
  • Coffey GP; Biology and Pharmacology, Portola Pharmaceuticals, Inc., South San Francisco, California. gcoffey@portola.com.
  • Feng J; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Betz A; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Pandey A; Medicinal Chemistry and Chemical Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Birrell M; Corporate Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Leeds JM; Drug Metabolism and Pharmacokinetics, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Der K; Pharmacokinetics, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Kadri S; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Lu P; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Segal J; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Wang YL; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Michelson G; Clinical Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Curnutte JT; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California.
  • Conley PB; Biology, Portola Pharmaceuticals, Inc., South San Francisco, California.
Clin Cancer Res ; 25(4): 1174-1184, 2019 02 15.
Article en En | MEDLINE | ID: mdl-30333224
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonas / Linfoma no Hodgkin / Linfoma de Células B / Quinasas Janus / Quinasa Syk Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonas / Linfoma no Hodgkin / Linfoma de Células B / Quinasas Janus / Quinasa Syk Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos